Archive

Skip to content The CRC Digest Liquid biopsy marker mSEPT9 evaluated for CRC screening and monitoring Research assessed methylated Septin9 as a blood-based biomarker for colorectal cancer diagnosis, recurrence monitoring, and prognosis. (Clinica Chimica Acta) This content is informational only and does not constitute medical advice. Always consult your oncologist

Skip to content The CRC Digest Primary care providers surveyed on early-onset CRC awareness Study examined PCPs' knowledge of CRC symptoms and referral practices for patients under 50, addressing the rising incidence in younger adults. (Population Health Management) This content is informational only and does not constitute medical advice.

Skip to content The CRC Digest ♥ Primary care providers' awareness of early-onset CRC symptoms examined Survey assessed primary care providers' knowledge of colorectal cancer symptoms and referral practices for patients under age 50, as incidence and death rates continue rising in this population. (Population Health Management) This content